UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049081
Receipt number R000055903
Scientific Title A validation study of sedation in cataract surgery using low-concentration nitrous oxide anesthesia A crossover design
Date of disclosure of the study information 2022/09/30
Last modified on 2022/09/30 16:35:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A validation study of sedation in cataract surgery using low-concentration nitrous oxide anesthesia A crossover design

Acronym

A study on the sedative effect in cataract surgery using low-concentration nitrous oxide anesthesia

Scientific Title

A validation study of sedation in cataract surgery using low-concentration nitrous oxide anesthesia A crossover design

Scientific Title:Acronym

A study on the sedative effect in cataract surgery using low-concentration nitrous oxide anesthesia

Region

Japan


Condition

Condition

Cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the Sedative Effects of Low-Concentration nitrous oxide anesthesia in Cataract Surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Bispectral Index

Key secondary outcomes

Heart rate, oxygen saturation, upper extremity systolic and diastolic blood pressure, subjective questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Type of inhaled gas during surgery for both eyes cataract surgery Low-concentration nitrous oxide anesthesia in the first eye, oxygen only in the second eye

Interventions/Control_2

Type of inhaled gas during surgery for both eyes cataract surgery Oxygen only in the first eye, low-concentration nitrous oxide anesthesia in the second eye

Interventions/Control_3

Type of inhaled gas at surgery for both eyes cataract surgery Oxygen only for 1st eye, Oxygen only for 2nd eye

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

67 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Cataract patients who underwent consecutive binocular cataract surgeries

Key exclusion criteria

Patients with known neurological disorders such as epilepsy, patients taking antipsychotic drugs, patients with previous stroke, patients with implanted cardiac pacemakers, and patients with nasal obstruction disease

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Morii

Organization

Medical corporation Asagiri Hospital

Division name

opthalmology

Zip code

673-0852

Address

1120-2 Asagiridai, Akashi-shi, Hyogo, Japan

TEL

078-912-7575

Email

k-morii@asagiri-hp.or.jp


Public contact

Name of contact person

1st name Koutarou
Middle name
Last name Ishigami

Organization

Medical corporation Asagiri Hospital

Division name

Clinical Engineering Technician Office

Zip code

673-0852

Address

1120-2 Asagiridai, Akashi-shi, Hyogo, Japan

TEL

078-912-7575

Homepage URL


Email

koutarou19931010@yahoo.co.jp


Sponsor or person

Institute

Medical corporation Asagiri Hospital

Institute

Department

Personal name



Funding Source

Organization

self-procurement
Medical corporation Asagiri Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Yoshinokukai Asagiri Hospital Ethics Review Committee

Address

1120-2 Asagiridai, Akashi-shi, Hyogo, Japan

Tel

0778-912-7575

Email

asagiri@asagiri-hp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 08 Month 27 Day

Date of IRB

2021 Year 09 Month 11 Day

Anticipated trial start date

2021 Year 03 Month 05 Day

Last follow-up date

2021 Year 12 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 09 Month 30 Day

Last modified on

2022 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055903


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name